SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES for SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOE AUGUSTUS | — |
| CHRIS HOWARD | — |
| CHRISTINE HEWITT LANZA | — |
| MICHAEL MORROW | — |
| DANIEL TROPE | — |
Tobacco TOB
Outreach and monitoring related to the tobacco industry. Congressional outreach and monitoring related to federal excise taxes, including: -H.R. 3407 / S. 411, MOMMA's Act. -H.R. 2786 / S. 1314, Tobacco Tax Equity Act. Congressional outreach and monitoring related to Congressional priorities on tobacco products and flavorings. Congressional outreach and monitoring related to H.R. 4356 /Senate draft, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, FY2022. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation including: -H.R. 1319, American Rescue Plan Act of 2021. Monitored the following: -FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, federal excise taxes, and tobacco product user fees. -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Proposed Rule, Tobacco Product Standard for Characterizing Flavors in Cigars (RIN 0910-AI28) -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOE AUGUSTUS | — |
| CHRIS HOWARD | — |
| CHRISTINE HEWITT LANZA | — |
| MICHAEL MORROW | — |
| DANIEL TROPE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.